<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Even though autoantibodies to pancreatic islet cells are normally found in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000855'>insulin-resistance</z:hpo> due to overweight is more reminiscent of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, some studies have described Î²-cell antibodies also in <z:hpo ids='HP_0004904'>maturity-onset diabetes of the young</z:hpo> (MODY) and in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>A 7-year-old girl was referred to our Unit for incidental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and family history of MODY2 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic evaluation confirmed mutation L134P in exon 4 of the glucokinase gene and a high HLA-risk of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>During follow-up, she developed type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and overweight-induced <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The coexistence of MODY, type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and overweight-induced <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> confirms that <z:mp ids='MP_0002055'>diabetes</z:mp> subtype probably represents a continuum of immune and metabolic dysfunction modified by genetic factors </plain></SENT>
</text></document>